A

Avantor

Global provider of high-purity lab materials

Major Account Manager

Full-TimeUpdated on 10/23/2026Deadline 10/30/26
No salary listed
Mid
Bachelor's
Raleigh, NC, USA+2 moreMore locations: Durham, NC, USA | North Carolina, USA
RemoteField-based in greater Raleigh-Durham; onsite with customers five days per week, with extensive regional travel.
Sales & Account ManagementAccount Management

About the job

Requirements
  • A college degree or equivalent/applicable experience is preferred.
  • Prefer 3+ years of experience working in a complex sales environment with multiple participants in purchasing decisions and a solution-based selling approach, or 3+ years in pharmaceutical manufacturing where stakeholder relationships are critical.
  • Proficiency with Microsoft Office Suite, including Teams.
  • B2B sales experience is preferred, particularly in distribution, life sciences, pharmaceutical manufacturing, bioprocessing, biotechnology, vaccine production, cell and gene therapy, or CDMO environments.
  • A proven track record of driving growth through consultative and strategic selling approaches in fast-paced, results-oriented environments.
  • Demonstrated success managing multiple stakeholders and using formal sales methodologies such as SPIN or Consultative Selling.
  • A scientific or technical background is preferred.
  • Willingness to travel to customer locations a minimum of five days per week and a valid driver's license are required.
Responsibilities
  • Own and grow a portfolio of strategic pharmaceutical and biopharmaceutical manufacturing accounts as the primary executive-level point of contact and trusted business partner.
  • Develop a deep understanding of customer business objectives, manufacturing priorities, operational challenges, quality requirements, and supply chain objectives to drive long-term partnership, retention, and growth.
  • Drive account-level growth by identifying strategic opportunities and using data, customer insights, and market trends to uncover whitespace, influence demand, and expand wallet share across the Avantor portfolio; use consultative, insight-led engagement to shape customer strategy beyond transactional selling.
  • Lead cross-functional account execution by leveraging local and global internal teams and external partners to deliver integrated solutions and achieve customer and revenue objectives.
  • Build relationships across procurement, supply chain, manufacturing, operations, quality, engineering, and executive leadership to identify opportunities and drive account growth.
  • Develop and execute strategic account plans, forecasts, and performance objectives, ensuring growth targets are achieved through disciplined account management, data-driven insights, and proactive customer engagement.
  • Build and sustain senior-level stakeholder relationships, leading strategic customer conversations that position Avantor as a trusted partner and advisor.
  • Manage complex customer interactions professionally and with influence, applying listening, organizational, and consultative questioning skills to build trust and alignment.
  • Synthesize and analyze sales and account data to inform strategy, support management decisions, and optimize account performance.
  • Manage time, priorities, and account complexity with high autonomy and accountability in a dynamic environment.
  • Lead commercial negotiations by developing and executing large-account pricing strategies, contract structures, and long-term commercial agreements.
Desired Qualifications
  • Experience with customer relationship management systems and sales analytical tools.

About the company

Avantor provides high-purity lab chemicals, consumables, and related services to life sciences, healthcare, and advanced technologies worldwide. Its products support research, development, manufacturing, and quality control across discovery to delivery. The company differentiates itself through a broad, vertically integrated portfolio and the VWR acquisition, enabling customers to source materials and services in one place. Its goal is to be a trusted global partner that helps scientific progress by supplying essential materials and support across life sciences and tech workflows.

Company Size

10,001+

Company Stage

IPO

Headquarters

Bristol, Pennsylvania

Founded

1904

Get referred to Avantor

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue hit $1.69 billion, and management raised 2026 guidance on July 29.
  • VWR returned to 1.7% organic growth in Q2 2026, ahead of schedule.
  • Todd Garner became CFO on September 21, 2026, sharpening financial discipline for deleveraging.

What critics are saying

  • In re Avantor securities litigation in Delaware targets VWR goodwill and competition disclosures.
  • Q2 2026 BMP revenue fell 5.6% organically, exposing fragile bioprocess demand.
  • Forty-nine employees were cut at Avantor Fluid Handling in July 2026, signaling ongoing restructuring.

What makes Avantor unique

  • Avantor owns VWR and NuSil, spanning distribution, silicones, and high-purity materials.
  • Avantor serves 300,000 customer locations across 180 countries, giving unmatched market reach.
  • Avantor's Revival program ties commercial, supply-chain, and e-commerce execution into one turnaround.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Wellness Program
  • Health Savings Account/Flexible Spending Account
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Employee Stock Purchase Plan
  • Paid Vacation
  • Paid Holidays
  • Unlimited Paid Time Off
  • Paid Sick Leave

Company News

Yahoo Finance
Oct 26th, 2026
Avantor appoints Mikey Santiago, a four-time CIO, as chief information officer

Avantor, a life sciences and advanced technology supplier listed on the NYSE, has appointed Mikey Santiago as chief information officer. Santiago will lead the company's global IT strategy and its digital transformation, supporting growth, customer experience, and innovation. He brings more than two decades of technology experience, including four stints as a CIO and senior roles at Danaher Corporation and its operating companies. He has led digital transformations, acquisitions and integrations, cloud modernisation, cybersecurity, and AI projects. "Mikey brings an exceptional combination of business knowledge, technology leadership, and a proven ability to execute transformation at scale," said Emmanuel Ligner, president and chief executive officer of Avantor.

PR Newswire
Sep 21st, 2026
Avantor appoints new Chief Financial Officer.

Avantor appoints new Chief Financial Officer. Sep 21, 2026, 06:05 ET RADNOR, Pa., Sept. 21, 2026 /PRNewswire/ - Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, appoints Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026. Garner will oversee the company's global finance organization, including financial planning and analysis, accounting, treasury, tax, investor relations and internal audit. Emmanuel Ligner, Avantor President and CEO, says: "Todd is a proven financial leader with deep operational expertise, a strong track record of driving growth and extensive experience partnering with boards, investors and management teams. He brings the strategic mindset, financial discipline and leadership capabilities needed to support our next phase of growth and value creation. I am delighted to welcome Todd to Avantor and look forward to working together as we execute our strategy and continue serving our customers around the world." Todd Garner says: "Avantor plays a critical role in advancing some of the most important work in the life sciences and advanced technologies industries. I am excited to join the Company and look forward to working with colleagues and partners worldwide to build on Avantor's strong foundation and create long-term value for our customers and shareholders." Garner recently comes from CONMED Corporation, where he served as Executive Vice President and Chief Financial Officer from 2018-2026. He brings more than 30 years of finance, operational and public company leadership experience. Garner's previous experience includes a variety of leadership roles at C. R. Bard, Inc., including Vice President, Investor Relations and Division CFO, where he helped support significant shareholder value creation and business growth. Garner holds a bachelor of science in accounting from Brigham Young University, a master of business administration from the University of Texas Rio Grande Valley, and is a certified public accountant. Steve Eck, Senior Vice President and Chief Accounting Officer (CAO), has been serving as Interim CFO since June 24, 2026, and will continue in his CAO role. Ligner says: "Steve stepped up and led the finance organization with a steady hand and great commitment. We thank him for his leadership during the transition period and are pleased he'll continue in this valuable role as our CAO." About Avantor Avantor(R) is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook. SOURCE Avantor and Financial News

Yahoo Finance
Jul 29th, 2026
Avantor beats Q2 earnings estimates with $1.69B revenue, EPS surprise of 10.5%

Avantor reported second-quarter 2026 revenue of $1.69 billion, up 0.5% year-over-year, exceeding the consensus estimate of $1.62 billion by 4.17%. Earnings per share came in at $0.21, down from $0.24 in the prior-year quarter, but beating the $0.19 consensus estimate by 10.53%. The VWR Distribution & Services segment generated $1.24 billion in revenue, surpassing the $1.12 billion analyst estimate. The Bioscience & Medtech Products segment brought in $451.8 million, falling short of the $490.86 million estimate. Avantor shares have returned 25.5% over the past month, outpacing the S&P 500's 1.9% gain. The stock currently holds a Zacks Rank #2 (Buy).

Yahoo Finance
Jul 29th, 2026
Avantor beats Q2 estimates with $0.21 EPS and $1.69B revenue, shares up 8.4% YTD

Avantor reported second-quarter earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.19 per share by 10.53%. This represents a decline from $0.24 per share a year ago. The company has surpassed consensus earnings estimates three times over the last four quarters. Revenue reached $1.69 billion for the quarter ended June 2026, exceeding the Zacks Consensus Estimate by 4.17%. This compares to year-ago revenues of $1.68 billion. Avantor shares have added about 8.4% since the beginning of the year versus the S&P 500's gain of 8.5%. The stock currently holds a Zacks Rank of number 2 (Buy), suggesting it is expected to outperform the market in the near future.

PR Newswire
Jul 29th, 2026
Avantor reports Q2 2026 sales of $1.69B, raises full-year organic growth and EPS guidance

Avantor reported second quarter 2026 results with net sales of $1,692.3 million, up 0.5% year-over-year but down 0.4% organically. The life sciences provider posted net income of $38.1 million and adjusted EBITDA of $254.3 million, with diluted earnings per share of $0.06. The company generated operating cash flow of $178.2 million and free cash flow of $142.8 million. It used proceeds to repay $112.1 million of debt. Chief Executive Emmanuel Ligner highlighted improved performance in the VWR Distribution and Services segment, which returned to positive organic revenue growth ahead of schedule. The Bioscience and Medtech Products segment performed near the high end of expectations. Avantor raised its full-year 2026 guidance, now expecting organic revenue growth of -0.5% to +0.5%, up from previous guidance of -2.5% to -0.5%. Adjusted earnings per share guidance increased to $0.80 to $0.83.